Alteogen's CEO Soon Jae Park's interview was released on August 13th 2025 in The Korea Economic Daily.

https://www.hankyung.com/article/2025081393151

This interview includes references to our plans regarding the establishment of biopharmaceutical manufacturing facilities as well as R&D initiatives.

Please be advised that, pursuant to mutual agreements with our partners, we do not disclose specific terms of license contracts, including royalty rates or milestone payments.
In addition, it is our established policy not to disclose details of SC development projects for which partner consent has not been obtained.

We further wish to clarify that any figures or product references appearing in analyst reports, media articles, or similar publications are based on independent estimates or industry data, and should not be interpreted as officially disclosed or confirmed information from our company.